Research
For over two decades, Bruce and his team have been developing and utilizing computer, AI, and systems approaches, methods, models, and tools to help decision makers better understand and address complex systems in health and public health. This has included the research efforts described below and other initiatives described here.
Bruce has been the Principal Investigator for over $60 million in grants/contracts from a variety of organizations and agencies including the National Institutes of Health (NIH), the Agency for Healthcare Quality and Research (AHRQ), the National Science Foundation (NSF), the Centers for Disease Control and Prevention (CDC), UNICEF, the Global Fund, the Bill & Melinda Gates Foundation, and the U.S. Agency for International Development (USAID).
Bruce and his PHICOR team have published over 295 publications in scientific peer-reviewed journals (e.g., The Lancet, Health Affairs, The New England Journal of Medicine, American Journal of Public Health, American Journal of Preventive Medicine) with Dr. Lee being first author for over 110 and last author for over 120 of them, most of which have been original research. Much of this research has involved working directly with a range of different local, state, national, and international decision-makers.
To find or sort these different scientific publications by topic, use the filtering option below and to the left.
Modeling Health and Economic Outcomes of Eliminating Sex Disparities in Youth Physical Activity
Modeling Health and Economic Outcomes of Eliminating Sex Disparities in Youth Physical Activity
Response to: “Quantifying the effect of vaccination on transmission in modelling studies”
Response to: “Quantifying the effect of vaccination on transmission in modelling studies”
What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?
What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?
How the Timing of Annual COVID-19 Vaccination of Nursing Home Residents and Staff Affects its Value.
How the Timing of Annual COVID-19 Vaccination of Nursing Home Residents and Staff Affects its Value.
Cost-Effectiveness of SARS-CoV-2 Testing and Isolation Strategies in Nursing Homes.
Cost-Effectiveness of SARS-CoV-2 Testing and Isolation Strategies in Nursing Homes.
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study.
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study
The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
The benefits of vaccinating with the first available COVID-19 coronavirus vaccine
The benefits of vaccinating with the first available COVID-19 coronavirus vaccine
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination
Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination
Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study
Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study
Estimated number of N95 respirators needed for healthcare workers in acute-care hospitals during the coronavirus disease 2019 (COVID-19) pandemic
Estimated number of N95 respirators needed for healthcare workers in acute-care hospitals during the coronavirus disease 2019 (COVID-19) pandemic
Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention
Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention
AJPM’s Paper of the Year 2020
The potential healthcare cost and resource use associated with COVID-19 coronavirus in the United States
The potential healthcare cost and resource use associated with COVID-19 coronavirus in the United States